Le produit a bien été ajouté au panier.

discount label
Ac-ATWLPPR-NH2
Vue en 3D

Biosynth logo

Ac-ATWLPPR-NH2

Ref. 3D-PP46515

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 10 décembre 2024

Informations sur le produit

Nom :
Ac-ATWLPPR-NH2
Synonymes :
  • Ac-Ala-Thr-Trp-Leu-Pro-Pro-Arg-amide
Description :

Peptide Ac-ATWLPPR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-ATWLPPR-NH2 include the following: Peptide-based siRNA delivery system for tumor vascular normalization and gene silencing in 4T1 cells Y Yi, C Feng, M Yu, L Mei, M Wu, W Tao - STAR protocols, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2666166723000965 The presence of PEG on nanoparticles presenting the c [RGDfK]-and/or ATWLPPR peptides deeply affects the RTKs-AKT-GSK3beta-eNOS signaling pathway and T Jia , J Ciccione, T Jacquet, M Maurel - International Journal of , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517319305496 Heteromultivalent targeting of integrin alphavbeta3 and neuropilin 1 promotes cell survival via the activation of the IGF-1/insulin receptors T Jia , J Choi, J Ciccione, M Henry, A Mehdi , J Martinez - Biomaterials, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961217306993 Definition of bifunctional theranostic molecules for cancer treatment T Jia - 2016 - hal.sciencehttps://hal.science/tel-01686187/ Selective targeting of verteporfin to choroidal neovascularization mediated by a homing peptide to VEGF-R2 R Renno, Y Terada, MJ Haddadin - & Visual Science, 2002 - iovs.arvojournals.orghttps://iovs.arvojournals.org/article.aspx?articleid=2421221 Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis R Binetruy-Tournaire, C Demangel , B Malavaud - The EMBO , 2000 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/19.7.1525 Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool Q Zhang, Z Yang, J Zhang, Y Li, X Dang, J Qu - Bioorganic Chemistry, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0045206824001457 Peptide-conjugated nanoparticles for photodynamic therapy P Couleaud, D Bechet, R Vanderesse - researchgate.nethttps://www.researchgate.net/profile/Regis-Vanderesse/publication/50601116_Nanoparticles_for_Photodynamic_Therapy_Applications/links/00b7d5310437cb78e3000000/Nanoparticles-for-Photodynamic-Therapy-Applications.pdf Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties N Thomas, M Pernot, R Vanderesse, P Becuwe - Biochemical , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295210002455 Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice N Thomas, L Tirand, E Chatelut, F Plenat - Photochemical & , 2008 - Springerhttps://link.springer.com/article/10.1039/b718259g Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo N Thomas, D Bechet, P Becuwe, L Tirand - of Photochemistry and , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1011134409000669 Protease-resistant peptides for targeting and intracellular delivery of therapeutics MC Lucana, Y Arruga, E Petrachi, A Roig, R Lucchi - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/12/2065 Stability of peptides and therapeutic success in cancer M Pernot, R Vanderesse, C Frochot - Expert Opinion on , 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/17425255.2011.574126 A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human L Tirand, C Frochot, R Vanderesse, N Thomas - Journal of Controlled , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365905006905 The neuropilin-1 inhibitor, ATWLPPR peptide, prevents experimental diabetes-induced retinal injury by preserving vascular integrity and decreasing oxidative stress J Wang, S Wang, M Li, D Wu, F Liu, R Yang, S Ji, A Ji - PLoS , 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142571 A7RC peptide modified paclitaxel liposomes dually target breast cancer J Cao, R Wang, N Gao, M Li , X Tian, W Yang - Biomaterials , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/bm/c5bm00161g Imaging Integrin alphavbeta3 and NRP-1 Positive Gliomas with a Novel Fluorine-18 Labeled RGD-ATWLPPR Heterodimeric Peptide Probe H Wu, H Chen , D Pan, Y Ma, S Liang, Y Wan - Molecular imaging and , 2014 - Springerhttps://link.springer.com/article/10.1007/s11307-014-0761-0 A7RC Peptide Modified Paclitaxel Liposomes Dually Target Breast Cancer H Peng, Q Wang - scholar.archive.orghttps://scholar.archive.org/work/d6hmly7vrjdynim2ift764inxm/access/wayback/http://pdfs.semanticscholar.org/b448/46abe293301f28a4282d75d67a8c4e806b5f.pdf Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI H Benachour , A Sacašve , T Bastogne , C Frochot - Theranostics, 2012 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475218/ In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1 GY Perret, A Starzec, N Hauet, J Vergote - Nuclear medicine and , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0969805104000290 Design of RGD-ATWLPPR peptide conjugates for the dual targeting of alpha V beta 3 integrin and neuropilin-1 F Thoreau , L Vanwonterghem, M Henry - Organic & , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/ob/c8ob00669e Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application EE Kamarulzaman, R Vanderesse - Journal of , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2015.1131196 New peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1 for anti-vascular targeted photodynamic therapy EE Kamarulzaman, A Mohd Gazzali , S Acherar - International journal of , 2015 - mdpi.comhttps://www.mdpi.com/1422-0067/16/10/24059 Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice D Wu, Y Gao, L Chen, Y Qi, Q Kang, H Wang, L Zhu - Peptides, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978110000276 Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity D Tymecka, AK Puszko , PFJ Lipià „ski - European Journal of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523418307566 Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry CF Wang , S Auriola, J Hirvonen - Current Medicinal , 2014 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2014/00000021/00000010/art00007 Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1 A Starzec, R Vassy, A Martin, M Lecouvey - Life sciences, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0024320506006084 of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex A Starzec, P Ladam, R Vassy, S Badache - Peptides, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978107003853 neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex A Starzec, P Ladam, R Vassy, S Badache - 2007 - academia.eduhttps://www.academia.edu/download/49851582/Structure-function_analysis_of_the_antia20161025-23988-1obl1yo.pdf Optimization of multifunctional nanoparticles for improvements of photodynamic efficiency, tumor selectivity and MRI detection A Seve - 2013 - inis.iaea.orghttps://inis.iaea.org/search/search.aspx?orig_q=RN:54020364

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP46515 Ac-ATWLPPR-NH2

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".